Skip to main content Accessibility help
×
Home

Incidence and Risk Factors for Infection Following Transcatheter Aortic Valve Implantation

  • Yuhao Shi (a1), Harindra C. Wijeysundera (a1) (a2), Stephen E. Fremes (a1) (a3) and Andrew E. Simor (a1) (a4)

Abstract

We identified risk factors for infection following transcatheter aortic valve implantation (TAVI); infection occurred in 35 (13.8%) of 253 patients. Variables associated with infection included chronic obstructive pulmonary disease (OR, 1.2; 95% CI, 1.1–1.4), postprocedural hemorrhage (OR, 1.2; 95% CI, 1.0–1.3), and procedure-related stroke (OR, 1.6; 95% CI, 1.3–2.1).

Infect Control Hosp Epidemiol 2016;37:1094–1097

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Incidence and Risk Factors for Infection Following Transcatheter Aortic Valve Implantation
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Incidence and Risk Factors for Infection Following Transcatheter Aortic Valve Implantation
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Incidence and Risk Factors for Infection Following Transcatheter Aortic Valve Implantation
      Available formats
      ×

Copyright

Corresponding author

Address correspondence to Dr. Andrew E. Simor, Department of Microbiology, Sunnybrook Health Sciences Centre, B103-2075 Bayview Avenue, Toronto, ON, Canada M4N 3M5 (andrew.simor@sunnybrook.ca).

References

Hide All
1. Horan, TC, Andrus, M, Dudeck, MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008;36:309332.
2. Kappetein, AP, Head, SJ, Généreux, P, et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation. The Valve Academic Research Consortium-2 consensus document. J Am Coll Cardiol 2012;60:14381454.
3. Van Mieghem, NM, van der Boon, RM, Nuis, R-J, et al. Cause of death after transcatheter aortic valve implantation. Cath Cardiovasc Interv 2014;83:E277E282.
4. van der Boon, RMA, Nuis, R-J, Benitez, LM, et al. Frequency, determinants and prognostic implications of infectious complications after transcatheter aortic valve implantation. Am J Cardiol 2013;112:104110.
5. Barbash, IM, Finkelstein, A, Barsheshet, A, et al. Outcomes of patients at estimated low, intermediate, and high risk undergoing transcatheter aortic valve implantation for aortic stenosis. Am J Cardiol 2015;116:19161922.
6. Amat-Santos, IJ, Messika-Zeitoun, D, Eltchaninoff, H, et al. Infective endocarditis after transcatheter aortic valve implantation. Results from a large multicenter registry. Circulation 2015;131:15661574.
7. Olsen, NT, de backer, O, Thyregod, HGH, et al. Prosthetic valve endocarditis after transcatheter aortic valve implantation. Circ Cardiovasc Interv 2015;8:e001939. DOI:10.1161/circinterventions.114.001939.
8. Biancari, F, Rosato, S, D’Errigo, P, et al. Immediate and intermediate outcome after transapical versus transfemoral transcatheter aortic valve replacement. Am J Cardiol 2016;117:245251.
9. Van Mieghem, NM, Tchetche, D, Chieffo, A, et al. Incidence, predictors, and implications of access site complications with transfemoral transcatheter aortic valve implantation. Am J Cardiol 2012;110:13611367.
10. Egron, S, Kütting, M, Marzelle, J, Becquemin, JP, Schmitz-Rode, T, Steinseifer, U. What can be done for cerebral embolic protection in TAVI? Analysis in the light of 10 years’ experience with protected carotid artery stenting. Expert Rev Med Devices 2016;13:1529.
Type Description Title
WORD
Supplementary materials

Shi supplementary material
Table

 Word (16 KB)
16 KB

Incidence and Risk Factors for Infection Following Transcatheter Aortic Valve Implantation

  • Yuhao Shi (a1), Harindra C. Wijeysundera (a1) (a2), Stephen E. Fremes (a1) (a3) and Andrew E. Simor (a1) (a4)

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed